Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Eczema & Psoriasis Relief - Discover Phoilex's Steroid-Free, Botanical Power


News provided by

Phoilex

Jun 27, 2024, 08:53 ET

Share this article

Share toX

Share this article

Share toX


Phoilex, a botanically-derived, steroid-free wellness brand for eczema and psoriasis sufferers, is launching today at the Eczema Expo in Denver, Colorado.

NEW YORK, June 27, 2024 /PRNewswire-PRWeb/ -- Launching today at the Eczema Expo in Denver, Colorado, Phoilex is a clinically-proven, steroid-free wellness brand for those struggling with chronic eczema, atopic dermatitis, psoriasis or hypersensitive skin. Phoilex offers a gentle yet powerful plant-based alternative to traditional steroidal treatments.

Founded by Sarina Pilaroscia, Phoilex was born from necessity. Inspired by her journey battling eczema and witnessing her father's lifelong struggle with psoriasis and the pain of Topical Steroid Withdrawal Syndrome (TSW), Pilaroscia sought to create products to relieve skin flare-ups without the use of harsh chemicals or the risk of developing a dependency on topical steroids.

"Everyone deserves to feel comfortable in their own skin," says Pilaroscia. "Phoilex is more than just skincare; it's about addressing the root cause of skin conditions and restoring peace of mind through clinically-proven, botanically-derived formulas."

Post this

"Everyone deserves to feel comfortable in their own skin," says Pilaroscia. "Phoilex is more than just skincare; it's about addressing the root cause of skin conditions and restoring peace of mind through clinically-proven, botanically-derived formulas."

Why Ditch the Steroids?
Unlike traditional treatments that often rely on corticosteroids, Phoilex avoids these ingredients all together. Corticosteroids, also known as topical steroids, can provide temporary relief, but their long-term use can lead to a condition called Topical Steroid Withdrawal (TSW). TSW can cause a worsening of symptoms and significant discomfort. Phoilex offers a safe and effective alternative for long-term skin health.

Powerful Relief Delivered Naturally:
Phoilex uses a proprietary blend of natural ingredients formulated to target specific concerns. The Phoilex Phyto-Active Blend™ features herbs and full-spectrum CBD, working together to reduce inflammation, promote wound healing, and deeply hydrate the skin. The Phyto-Active Blend™ is in all Phoilex products and includes powerful anti-inflammatory ingredients such as nettle leaf, mullein leaf, birch bark, arnica root, chaga mushroom, and calendula flower.

  • Active RELEAF Spot Gel ($58 / 60 ML): This innovative formula provides fast-acting relief for irritated, itchy, burning or wounded skin. Its unique blend of powerful ingredients, including 4% colloidal oatmeal, a ceramide complex, a triple vitamin D3 complex, and bisabolol, works synergistically to calm discomfort and accelerate the skin's natural healing process. In a clinical trial, over 93% of participants reported immediate relief from skin inflammation and the feeling of itchiness for up to 4 hours of use. 74% of participants noticed a decline in flares after 8 weeks of use.
  • Liverty Tincture ($48 / 30 ML): Taking an internal approach to managing eczema and psoriasis, this plant-based tincture harnesses the power of nature to promote overall well-being and reduce flare-ups. By supporting the liver's natural detoxification process and promoting a healthy nervous system, Liverty Tincture strengthens the body's resilience.

This regimen fosters skin health from within, aiming to help reduce eczema and psoriasis triggers.

Phoilex is committed to ethical sourcing and cruelty-free practices. All products are free of harsh chemicals, and clinically proven to offer a gentle yet effective solution for even the most sensitive skin. Products are available exclusively at phoilex.com.

Phoilex is also an avid supporter of the International Topical Steroid Awareness Network (ITSAN) which advocates, educates, raises awareness, and provides support for the 31 million Americans currently living with eczema (National Eczema Association) and the 12% of eczema patients who develop Topical Steroid Withdrawal (Fukaya et al).

About Phoilex
Phoilex is a skincare and wellness brand dedicated to offering alternative, steroid-free solutions for those struggling with sensitive skin conditions. Founded by Sarina Pilaroscia, a woman who has struggled with eczema her entire life, and a team of top pharmacists, chemists, dermatologists, and nutritionists, Phoilex is proud to create a line of effective, thoughtfully-formulated products that empower individuals to turn over a new leaf in the management of eczema, psoriasis, and sensitive skin conditions.

Follow #PhoilexFam and @phoilex.releaf on Instagram.

Media Contact

Julia Labaton, RED PR LLC, 646-528-3969, [email protected], www.red-pr.com

Samantha Gonda, RED PR LLC, 978-868-6977, [email protected], www.red-pr.com

SOURCE Phoilex

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.